NCT04426006

Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic

Serological Response to SARS-Cov-2 Virus in Personnel of the Institut Bergonié in the Context of the COVID-19 Pandemic - PRO-SERO-COV

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 526 (actual)
• Sponsor: Institut Bergonié · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The question of the immune response of the population, particularly of professional populations in contact with vulnerable populations (such as those with chronic conditions such as cancer), is an important issue. Knowing the evolution of this response over time in this population can help answer outstanding questions. The PRO-SERO-COV study is a seroprevalence study of caregivers working in the hospital sector with a follow-up at 3 months and 12 months. The objective is to evaluate and monitor at 3 and 12 months the serological immune status to an infection by the SARS-CoV-2 virus in active volunteer professionals working at the Institut Bergonié with different types of exposure: healthcare professionals and professionals in other services.

Conditions

• Sars-CoV2
• Serum; Disease

Interventions

Type	Name	Description
OTHER	PRO-SERO-COV	At inclusion, 3 months and 12 months : * blood sample (2 x 5ml) * self-administered questionnaire

Timeline

• Start date: 2020-06-18
• Primary completion: 2021-01-26
• Completion: 2021-10-04
• First posted: 2020-06-11
• Last updated: 2025-09-03
• Results posted: 2024-01-12

Locations

1 site across 1 country: France